In recent years, the popularity of weight-loss drugs like Ozempic and Wegovy has soared so dramatically that they’ve inspired new vocabulary, spurred global shortages, and prompted moral debates.

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...

A $4.4 million shortfall in the city’s health insurance trust fund is a result of rising medical costs, including from the classification of drugs that include weight loss ...

For many, the high cost of the injection means stopping is a matter of 'when,' not 'if.' Endocrinologists reveal the crucial ...

A mother-of-three who shed two stone in just nine weeks thanks to a skinny jab has warned users of a painful side-effect that ...

School districts across Minnesota are struggling to contain double-digit health insurance cost increases. Some officials say ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...

Pa. human services advocates say proposed federal Medicaid cuts would deliver a devastating blow to systems that are already ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...